BackgroundThe association of human papillomavirus (HPV) with cervical cancer is well established.AimTo investigate HPV genotype distribution and co-infection occurrence in cervical specimens from a group of Egyptian women.MethodsA group of 152 women with and without cervical lesions were studied. All women had cervical cytology and HPV testing. They were classified according to cytology into those with normal cytology, with squamous intraepithelial lesions (SIL) and invasive squamous cell carcinoma (SCC). Cervical samples were analyzed to identify the presence of HPV by PCR, and all positive HPV-DNA samples underwent viral genotype analysis by means of LINEAR ARRAY HPV Genotyping assay.ResultsA total of 26 HPV types with a prevalence of 40.8 % were detected. This prevalence was distributed as follows: 17.7 % among cytologically normal females, 56.5, 3.2, and 22.6 % among those with LSIL, HSIL and invasive SCC respectively. Low-risk HPV types were detected in 81.8 % of the cytologically-normal women, in 5.7 % of those in LSIL women, and in 14.3 % of infections with invasive SCC, while no low-risk types were detected in HSIL. High-risk HPV types were detected in 18.2 % of infections in the cytologically normal women, 14.3 % of infections in LSIL, and in 21.4 % of invasive lesions. The probable and possible carcinogenic HPV were not detected as single infections. Mixed infection was present in 80 % of women with LSIL, in 100 % of those with HSIL, and in 64.3 % of those with invasive SCC. This difference was statistically significant. HPV 16, 18 and 31 were the most prevalent HR HPV types, constituting 41.9, 29.03 and 12.9 % respectively, and HPV 6, 62 and CP6108 were the most prevalent LR HPV types constituting 11.3, 9.7 and 9.7 % respectively.ConclusionThese data expand the knowledge concerning HPV prevalence and type distribution in Egypt which may help to create a national HPV prevention program. HPV testing using the LINEAR ARRAY HPV Genotyping assay is a useful tool when combined with cytology in the diagnosis of mixed and non-conventional HPV viral types.
T YPHOID fever a food-borne disease caused by Salmonella species, is a worldwide prevalent disease. In endemic areas, children are at highest risk owing to weaning from passively acquired maternal antibody and lack of acquired immunity. Several studies have been done to clarify the pathogenesis and underlying immune aspects of typhoid fever. The Objective is to study the changes of some proinflammatory cytokines in plasma of children and adults with typhoid fever and resistance to therapy. This study included 128 cases from which 34 consecutive children and adult admitted to Benha Fever Hospital with proven diagnosis of typhoid fever patients with typhoid fever resistant to combined therapy with Ciprofloxacin and Cefotax in addition to Zithrokan and Zantac have higher plasma levels of IL-6 and TNF-alpha. Toxic look, constipation and splenomegaly may be considered as indicators of drug resistance. Study of changes in the levels of some cytokines may offer a new dimension in the assessment of the clinical efficacy of antimicrobial therapy.
A CINETOBACTER baumannii (A. baumannii) is considered one of the predominant antibiotic resistance pathogens involved in hospital acquired infections worldwide problem. The study investigated the effect of antibiotic combination of β-lactams (ceftriaxone, cefixime, carpabenem and impenim) and aminoglycosides against 5 clinical isolates of A. baumannii multidrug resistant. Over one year, 250 bacterial isolates were collected from 5 Egyptian hospitals from various infection sites. Two hundred out of 250 bacterial isolates were identified as A. baumannii based on phenotypic and genotypic techniques. The susceptibility of two-hundred A. baumannii strains against 21 different antibiotics was studied. The results showed that the highest resistance was to Cephalosporins, group was 99% followed by Quinolones & Fluoroquinolone was 90, 5 followed by penicillin 87.5, then Sulfa drugs was 75.5 then Carbapenem was 73 and finally Aminoglycosides was 60.5%. The minimum inhibitory concentration (MICs) values of aminoglycosides resistant A. baumannii strains ranged from 32 to >512mg/ml and β-lactam group ranged from 16 to >512mg/ml. Fortyfive combined microtitre checkerboards were performed against the 5 totally aminoglycoside resistant A. baumannii strains to assess the potential for combination therapy. Combination of aminoglycoside antibiotics with β-lactams showed synergy action in thirty-eight (84%) of total forty-five combinations. Synergy was achieved with 100%, with the following combinations GN/IMP, GN/CRO, GN/CFM, AK/CRO, AK/CFM, TOB/CRO and TOB/CFM. No synergism was observed with combination between amikacin and imipenem.
Chitosan and alginate salts are natural biopolymers that have gained recent attention in the biomedical sectors. Their properties allow them to become potential candidates as safe, cheap, and effective vaccine adjuvants. The present study aimed to enhance the immunogenic response of a current injectable killed cholera vaccine (KCV) using chitosan and alginate salt as natural adjuvants against alum. We tested KCV adjuvanted with alum, chitosan, and sodium alginate in mice. Mice were immunized intraperitoneally with KCV adjuvanted with alum, chitosan, or alginate salt and compared with a control unadjuvanted immunized group. Humoral, cellular, and functional immune responses were evaluated in all groups. The addition of adjuvants, particularly natural adjuvants, to KCV significantly improved the immune response as demonstrated by specific antibody increase, strong proliferation effects, and high protection rate against different challenge doses of cholera strains. Our findings demonstrate that chitosan and alginate salt are superior adjuvants for boosting the KCV immune response and highlights the requirement for further vaccine development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.